相似文献
1
Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea.
Iran J Med Sci. 2014 Jan;39(1):60-3.
2
Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea.
Hematology. 2012 Mar;17(2):122-4. doi: 10.1179/102453312X13221316477778.
3
Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran.
Iran Red Crescent Med J. 2015 Jul 1;17(7):e28343. doi: 10.5812/ircmj.17(5)2015.28343. eCollection 2015 Jul.
4
Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.
Iran Red Crescent Med J. 2014 Jul;16(7):e18712. doi: 10.5812/ircmj.18712. Epub 2014 Jul 5.
5
Study of thyroid function in Egyptian children with β-thalassemia major and β-thalassemia intermedia.
J Egypt Public Health Assoc. 2013 Dec;88(3):148-52. doi: 10.1097/01.EPX.0000436490.10201.28.
6
Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran.
J Pediatr Hematol Oncol. 2005 Jul;27(7):380-5. doi: 10.1097/01.mph.0000174386.13109.28.
7
Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.
Eur J Haematol. 2009 Mar;82(3):213-8. doi: 10.1111/j.1600-0609.2008.01192.x. Epub 2008 Dec 5.
8
Comparative study of radiographic and laboratory findings between Beta thalassemia major and Beta thalassemia intermedia patients with and without treatment by hydroxyurea.
Iran Red Crescent Med J. 2015 Feb 1;17(2):e23607. doi: 10.5812/ircmj.23607. eCollection 2015 Feb.
9
Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
Ann Hematol. 2014 Dec;93(12):2045-50. doi: 10.1007/s00277-014-2154-5. Epub 2014 Jul 27.
10
Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experience.
Pediatr Hematol Oncol. 2010 Apr;27(3):205-11. doi: 10.3109/08880011003639952.
引用本文的文献
1
Prevalence and factors associated with hypothyroidism in children with sickle cell anemia aged 6 months - 17 years attending the Sickle Cell Clinic, Mulago Hospital, Uganda; a cross-sectional study.
BMC Endocr Disord. 2023 Mar 13;23(1):60. doi: 10.1186/s12902-023-01317-2.
2
Evaluation of thyroid hormones and ferritin level in patients with β-thalassemia.
Med Pharm Rep. 2022 Apr;95(2):152-157. doi: 10.15386/mpr-2053. Epub 2022 Apr 28.
3
Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran.
Int J Endocrinol Metab. 2018 Feb 10;16(2):e13228. doi: 10.5812/ijem.13228. eCollection 2018 Apr.
4
Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.
Biomed Res Int. 2015;2015:813098. doi: 10.1155/2015/813098. Epub 2015 Mar 5.
本文引用的文献
1
β-thalassemia and thyroid failure: is there a role for thyroid autoimmunity?
Pediatr Endocrinol Rev. 2011 Mar;8 Suppl 2:307-9.
2
Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experience.
Pediatr Hematol Oncol. 2010 Apr;27(3):205-11. doi: 10.3109/08880011003639952.
3
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.
Blood. 2010 Mar 11;115(10):1886-92. doi: 10.1182/blood-2009-09-243154. Epub 2009 Dec 23.
4
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).
Blood. 2010 Mar 25;115(12):2354-63. doi: 10.1182/blood-2009-05-221333. Epub 2009 Nov 10.
5
Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:174-80.
6
Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.
Thromb Haemost. 2006 Oct;96(4):488-91.
7
Thalassemia intermedia: revisited.
Blood Cells Mol Dis. 2006 Jul-Aug;37(1):12-20. doi: 10.1016/j.bcmd.2006.04.005. Epub 2006 Jun 5.
8
Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran.
J Pediatr Hematol Oncol. 2005 Jul;27(7):380-5. doi: 10.1097/01.mph.0000174386.13109.28.
9
Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.
Chest. 2005 May;127(5):1523-30. doi: 10.1378/chest.127.5.1523.
10
Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia.
Blood. 2003 Aug 15;102(4):1529-30. doi: 10.1182/blood-2003-01-0117. Epub 2003 Apr 17.
Zotero 插件